Royal Bank Of Canada Bria Cell Therapeutics Corp. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.72 - $7.58 $20,592 - $27,288	3,600 New	3,600 $23,000
Q4 2022 Feb 14, 2023	BUY	$4.28 - $6.03 $727 - $1,025	170 Added 2428.57%	177 $0
Q3 2022 Nov 14, 2022	SELL	$3.0 - $8.31 $501 - $1,387	-167 Reduced 95.98%	7 $0
Q2 2022 Aug 15, 2022	BUY	$4.28 - $11.9 $744 - $2,070	174 New	174 $1,000
Q1 2022 May 16, 2022	SELL	$5.91 - $10.14 $1,672 - $2,869	-283 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	$7.1 - $10.61 $2,009 - $3,002	283 New	283 $3,000
Q3 2021 Nov 15, 2021	SELL	$4.4 - $9.28 $30 - $64	-7 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.89 - $6.57 $20 - $45	7 New	7 $0

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.